Skip to content

Continuous Cuffless Blood Pressure Measurement with Wearable Ring in Patients with Heart Failure

Continuous Cuffless Blood Pressure Measurement with Wearable Ring in Patients with Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010425
Enrollment
100
Registered
2025-04-18
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Uijeongbu St. Mary’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diagnosis of Heart Failure (Heart failure is diagnosed based on the 2022 Korean Society of Heart Failure guidelines. It refers to cases where a patient with risk factors, symptoms, and/or signs suggestive of heart failure, as well as electrocardiographic abnormalities, shows findings consistent with heart failure through NT-proBNP testing and echocardiography.) 2.Patients Requiring Medication That Affects Blood Pressure or Pulse This includes study participants who require administration of medications associated with blood pressure fluctuations, such as angiotensin receptor-neprilysin inhibitors, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, mineralocorticoid receptor antagonists, SGLT2 inhibitors, loop diuretics, or vasodilators. Additionally, it includes those who require medications affecting pulse rate, such as ivabradine, digoxin, or amiodarone, necessitating blood pressure and pulse monitoring. 3.Aged 19 Years or Older and Providing Voluntary Consent

Exclusion criteria

Exclusion criteria: - When blood pressure calibration using a traditional cuff-based sphygmomanometer on both upper limbs is not possible - When the smart ring cannot be worn on either hand - When there is a significant difference in blood pressure between both upper limbs (defined as a systolic blood pressure difference of =20 mmHg or a diastolic blood pressure difference of =10 mmHg) - When there is peripheral vascular disease in the upper limb arteries (=50% stenosis in the subclavian, brachial, ulnar, or radial artery, or a history of angioplasty, stent placement, or surgical treatment) - When there is an abnormal Allen test result

Design outcomes

Primary

MeasureTime frame
Blood Pressure/Pulse

Countries

Korea, Republic of

Contacts

Public Contactdaseul kim

The Catholic University of Korea, Uijeongbu St. Mary’s Hospital

dasle0312@naver.com+82-31-820-3965

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026